IDO1 and migraine disorder: In a nitroglycerin administration rodent model, Nagy-Grócz et al. [67] demonstrated that migraine may be related to decreased expression of KYN pathway enzymes (kynurenine amino transferase-II (KAT-II), IDO, TDO, KYNU, KMO).